1 Distribution of Anti-CTLA-4 mAb between the central and lymph node compartments
2 Distribution of Anti-CTLA-4 mAb between the central and leaky tissues
3 Distribution of Anti-CTLA-4 mAb between the central and tight tissues
4 Distribution of Anti-CTLA-4 mAb between the central and tumor compartments
5 Clearance of Anti-CTLA-4 mAb from the central compartment
6
The generation of Effector T cells and their migration into the blood/plasma from the designated number of lymph nodes as a
multiple of that from a single lymph node
7 Trafficking of free Effector T cells from blood to GI vasculature
8 Trafficking of free Effector T cells from blood to Liver vasculature
9 Trafficking of free Effector T cells from blood to Spleen vasculature
10 Trafficking of free Effector T cells from blood to Lymph Node vasculature
11 The natural turnover of Effector T cells in the blood
12 Trafficking of free Effector T cells from blood to Peripheral (other tissues not directly accounted for) vasculature
13 Trafficking of free Effector T cells from blood to Tumor vasculature
14 Distribution of Anti-PD-1 mAb between the central and lymph node compartments
15 Distribution of Anti-PD-1 mAb between the central and leaky tissues
16 Distribution of Anti-PD-1 mAb between the central and tight tissues
17 Distribution of Anti-PD-1 mAb between the central and tumor compartments
18 Clearance of Anti-PD-1 mAb from the central compartment
19 Distribution of Anti-PD-L1 mAb between the central and lymph node compartments
20 Distribution of Anti-PD-L1 mAb between the central and leaky tissues
21 Distribution of Anti-PD-L1 mAb between the central and tight tissues
22 Distribution of Anti-PD-L1 mAb between the central and tumor compartments
23 Clearance of Anti-PD-L1 mAb from the central compartment
24 Saturation of Anti-PD-L1 mAb clearance from the central compartment
25 Trafficking of Effector T cells from GI to Liver vasculature
26 Turnover of free Effector T cells in the GI vasculature
27 Extravasation of arrested Effector T cells from the Liver vasculature
28 Turnover of arrested Effector T cells in the Liver vasculature
29 Arrest of bound Effector T cells in the Liver vasculature
30 Detachment of bound Effector T cells in the Liver vasculature
31 Turnover of bound Effector T cells in the liver vasculature
32 Trafficking of free Effector T cells from Liver to Lung vasculature
33 Turnover of free Effector T cells in the liver vasculature
34 Trafficking of free Effector T cells from Liver to lymph node extravascular space
35 Turnover of Effector T cells in the Liver extravascular space
36 Extravasation of arrested Effector T cells from the Spleen vasculature
37 Turnover of arrested Effector T cells in the Spleen vasculature
38 Arrest of bound Effector T cells in the Spleen vasculature
39 Detachment of bound Effector T cells in the Spleen vasculature
40 Turnover of bound Effector T cells in the Spleen vasculature
41 Binding or free Effector T cells to the Spleen vasculature
42 Trafficking of free Effector T cells from Spleen to Liver vasculature
43 Turnover of free Effector T cells in the Spleen vasculature
44 Trafficking of free Effector T cells from Spleen to lymph node extravascular space
45 Turnover of Effector T cells in the Spleen extravascular space
46 Binding or free Effector T cells to the Liver vasculature
47 Extravasation of arrested Effector T cells from the Lungs vasculature
48 Turnover of arrested Effector T cells in the Lungs vasculature
49 Depletion of arrested Effector T cells in the Lungs vasculature
50 Binding or free Effector T cells to the Lungs vasculature
51 Trafficking of free Effector T cells from Lungs to (arterial) Blood
52 Turnover of free Effector T cells in the Lungs vasculature
53 Trafficking of free Effector T cells from Lungs to lymph node extravascular space
54 Turnover of Effector T cells in the Lungs extravascular space
55 Arrest of bound Effector T cells in the Lungs vasculature
56 Detachment of bound Effector T cells in the Lungs vasculature
57 Turnover of bound Effector T cells in the Lungs vasculature
58 Depletion of bound Effector T cells in the Lungs vasculature
59 Interaction at the immunological synapse between CD80 on Primed Naive T cells and PD-L1 on T Regulatory cells in the
lymph node
60 CD80 expression threshold on Primed Naive T cells for interaction with T Regulatory cells in the lymph node
61 Interaction at the immunological synapse between PD-1 on Primed Naive T cells and PD-L1 on T Regulatory cells in the
lymph node
62 Interaction at the immunological synapse between PD-1 on Primed Naive T cells and Anti-PD-1 mAb in the lymph node
63 PD-1 expression threshold on Primed Naive T cells for interaction with T Regulatory cells in the lymph node
64 Interaction at the immunological synapse between PD-L1 on Primed Naive T cells and Anti-PD-L1 mAb in the lymph node
65 PD-L1 expression threshold on Primed Naive T cells for interaction with T Regulatory cells in the lymph node
66 Inactivation of Naïve T cells by T Regulatory cells in the lymph node
67 Dissociation of T Regulatory cells from Naïve T cells in the lymph node without inactivation of the latter
68 Inactivation of Primed Naïve T cells by T Regulatory cells in the lymph node
69 Dissociation of T Regulatory cells from Primed Naïve T cells in the lymph node without inactivation of the latter
70 CD80 expression by Primed Naive T cells for interaction with T Regulatory cells in the lymph node
71 PD-1 expression by Primed Naive T cells for interaction with T Regulatory cells in the lymph node
72 PD-L1 expression by Primed Naive T cells for interaction with T Regulatory cells in the lymph node
73 PD-1 expression by T Regulatory cells for interaction with Primed Naive T cells in the lymph node
74 PD-L1 expression by T Regulatory cells for interaction with Primed Naive T cells in the lymph node
75 CD80 expression threshold on mAPCs for interaction with T Regulatory cells in the lymph node
76 CD86 expression threshold on mAPCs for interaction with T Regulatory cells in the lymph node
77 Interaction at the immunological synapse between CD80 on mAPCs and CTLA-4 on T Regulatory cells in the lymph node
78 Interaction at the immunological synapse between CD86 on mAPCs and CTLA-4 on T Regulatory cells in the lymph node
79 Interaction at the immunological synapse between CTLA-4 on T Regulatory cells and Anti-CTLA-4 mAb in the lymph node
80 CTLA-4 expression threshold on T Regulatory cells for interaction with mAPCs in the lymph node
81 Interaction at the immunological synapse between PD-L1 on Primed Naive T cells and PD-1 on T Regulatory cells in the
lymph node
82 Interaction at the immunological synapse between PD-1 on T Regulatory cells and Anti-PD-1 mAb in the lymph node
83 PD-1 expression threshold on Regulatory cells for interaction with Primed Naive T cells in the lymph node
84 Interaction at the immunological synapse between PD-L1 on T Regulatory cells and Anti-PD-L1 mAb in the lymph node
85 Interaction at the immunological synapse between PD-L1 on T Regulatory cells and Anti-PD-1 mAb in the lymph node
86 Phagocytosis of tumor debris by resident APCs in the lymph node
87 Decay of tumor debris in the lymph nodes
88 Lymph return of Anti-CTLA-4 to the blood
89 Interaction at the immunological synapse between CTLA-4 on Primed Naïve T cells during priming interactions with mAPCS
and Anti-CTLA-4 mAb in the lymph node
90 Internalization of the CTLA-4 receptor on Primed Naïve T cells following its binding to Anti-CTLA-4 mAb
91 Migration of Effector T cells from the lymph node into the blood (removal linked to regeneration by algebraic equation below)
92 Return of Effector T cells from lymph node extravascular space to the Lungs vascular space
93 Turnover of Effector T cells in the lymph node extravascular space
94 Trafficking of free Effector T cells from lymph node vascular space to the Lungs vascular space
95 Turnover of free Effector T cells in the lymph node vascular space
96 CD80 expression by total mAPCs in the lymph node
97 CD86 expression by total mAPCs in the lymph node
98 PD-1 expression by total mAPCs in the lymph node
99 PD-L1 expression by total mAPCs in the lymph node
100 PD-L2 expression by total mAPCs in the lymph node
101 Natural turnover of mAPCs in the lymph node
102 Inactivation of mAPCs in the lymph node as a result of CTLA-4 secreted from T Regulatory cells in the lymph nodes binding
to CD80 and CD86
103 CD80 expression threshold on mAPCs in the lymph node
104 CD86 expression threshold on mAPCs in the lymph node
105 CD80 expression by mAPCs that interact with Naive T cells in the lymph node
106 CD86 expression by mAPCs that interact with Naive T cells in the lymph node
107 CD80 expression threshold on mAPCs for interaction with Naive T cells in the lymph node
108 CD86 expression threshold on mAPCs for interaction with Naive T cells in the lymph node
109 CD80 expression by mAPCs that interact with Primed Naive T cells in the lymph node
110 CD86 expression by mAPCs that interact with Primed Naive T cells in the lymph node
111 PD-1 expression by mAPCs that interact with Primed Naive T cells in the lymph node
112 PD-L1 expression by mAPCs that interact with Primed Naive T cells in the lymph node
113 PD-L2 expression by mAPCs that interact with Primed Naive T cells in the lymph node
114 Interaction at the immunological synapse between CD80 on mAPCs and CTLA-4 on Primed Naïve T cells in the lymph node
115 Interaction at the immunological synapse between CD80 on mAPCs and PD-L1 on Primed Naïve T cells in the lymph node
116 CD80 expression threshold on mAPCs for interaction with Primed Naive T cells in the lymph node
117 Interaction at the immunological synapse between CD86 on mAPCs and CTLA-4 on Primed Naïve T cells in the lymph node
118 Interaction at the immunological synapse between CD86 on mAPCs and CD28 on Primed Naïve T cells in the lymph node
119 CD86 expression threshold on mAPCs for interaction with Primed Naive T cells in the lymph node
120 Interaction at the immunological synapse between PD-1 on mAPCs cells during priming interactions with Primed Naïve T
cells and Anti-PD-1 mAb in the lymph node
121 PD-1 expression threshold on mAPCs for interaction with Primed Naive T cells in the lymph node
122 PD-L1 expression threshold on mAPCs for interaction with Primed Naive T cells in the lymph node
123 Interaction at the immunological synapse between PD-L2 on mAPCs and PD-1 on Primed Naïve T cells in the lymph node
124 PD-L2 expression threshold on mAPCs for interaction with Primed Naive T cells in the lymph node
125 PD-1 expression threshold on total mAPCs in the lymph node
126 PD-L1 expression threshold on total mAPCs in the lymph node
127 PD-L2 expression threshold on total mAPCs in the lymph node
128 Engagement of Naïve T cells in the first priming phase in the lymph node
129 Naïve T cells cycling out of the lymph node
130 Naïve T cells being disengaged in the first priming phase without undergoing successful priming in the lymph node
131 Naïve T cells successfully undergoing the first priming phase in the lymph node
132 Transendocytosis of the CD80 receptors on mAPCs through CTLA-4 binding and internalization on Primed Naïve T cells in
the lymph node
133 Transendocytosis of the CD86 receptors on mAPCs through CTLA-4 binding and internalization on Primed Naïve T cells in
the lymph node
134 Interaction at the immunological synapse between CD80 on mAPCs cells and CD28 on Naïve T cells in the lymph node
135 Interaction at the immunological synapse between CD86 on mAPCs cells and CD28 on Naïve T cells in the lymph node
136 CD28 expression threshold on Naïve T cells in the lymph node
137 Naïve T cells expressing CD28 in the lymph node
138 Lymph return of Anti-PD-1 to the blood
139 Lymph return of Anti-PD-L1 to the blood
140 Interaction at the immunological synapse between PD-L1 on mAPCs involved in the second priming phase and Anti-PD-L1
mAb in the lymph node
141 Interaction at the immunological synapse between PD-L1 on Primed Naïve T cells involved in the second priming phase with
mAPCs and Anti-PD-L1 mAb in the lymph node
142 CTLA-4 expression threshold on Primed Naïve T cells for interaction with mAPCs in the lymph node
143 Interaction at the immunological synapse between CD80 on mAPCs and CD28 on Primed Naïve T cells in the lymph node
144 CD28 expression threshold on Primed Naïve T cells for interaction with mAPCs in the lymph node
145 Interaction at the immunological synapse between PD-L1 on mAPCs and CD80 on Primed Naïve T cells in the lymph node
146 CD80 expression threshold on Primed Naïve T cells for interaction with mAPCs in the lymph node
147 Interaction at the immunological synapse between PD-L1 on mAPCs and PD-1 on Primed Naïve T cells in the lymph node
148 Interaction at the immunological synapse between PD-1 on Primed Naïve T cells involved in the second priming phase with
mAPCs and Anti-PD-1 mAb in the lymph node
149 PD-1 expression threshold on Primed Naïve T cells for interaction with mAPCs in the lymph node
150 Interaction at the immunological synapse between PD-1 on mAPCs and PD-L1 on Primed Naïve T cells in the lymph node
151 PD-L1 expression threshold on Primed Naïve T cells for interaction with mAPCs in the lymph node
152 CTLA-4 expression by Primed Naïve T cells for interaction with mAPCs in the lymph node
153 CD28 expression by Primed Naïve T cells for interaction with mAPCs in the lymph node
154 CD80 expression by Primed Naïve T cells for interaction with mAPCs in the lymph node
155 PD-1 expression by Primed Naïve T cells for interaction with mAPCs in the lymph node
156 PD-L1 expression by Primed Naïve T cells for interaction with mAPCs in the lymph node
157 Primed Naïve T cells engaging in the second priming phase in the lymph node
158 Primed Naïve T cells unsuccessfully undergoing the second priming phase to become anergic T cells in the lymph node
159 Primed Naïve T cells engaged in the second priming phase disengaging form being primed in the lymph node
160 Primed Naïve T cells engaged in the second priming phase successfully undergoing priming to become Proliferating T cells in
the lymph node
161 Proliferating T cells becoming fully activated Effector T cells in the lymph node
162 Sets the proliferation threshold for Proliferating T cells in the lymph node
163 Internalization of the Anti-CTLA-4 antibodies bound to CTLA-4 receptors on T Regulatory cells in the lymph node
164 Transendocytosis of the CD80 receptors on mAPCs through CTLA-4 binding and internalization on T Regulatory cells in the
lymph node
165 Transendocytosis of the CD86 receptors on mAPCs through CTLA-4 binding and internalization on T Regulatory cells in the
lymph node
166 CTLA-4 expression on the surface of non-interacting T Regulatory cells in the lymph node
167 Interaction between T Regulatory cells and mAPCs in lymph node
168 Interaction between T Regulatory cells and Naïve T cells in lymph node
169 Interaction between T Regulatory cells and Primed Naïve T cells in lymph node
170 Dissociation of T Regulatory cells from mAPCs in the lymph node with inactivation of the latter
171 Dissociation of T Regulatory cells from mAPCs in the lymph node without inactivation of the latter
172 CD80 expression by mAPCs for interaction with T Regulatory cells in the lymph node
173 CD86 expression by mAPCs for interaction with T Regulatory cells in the lymph node
174 CTLA-4 expression by T Regulatory cells for interaction with mAPCs in the lymph node
175 Binding of Anti-CTLA-4 to CTLA-4 expressed on the surface of non-interacting T Regulatory in the lymph node
176 CTLA-4 expression threshold on non-interacting T Regulatory cells in the lymph node
177 Administration of Anti-CTLA-4 mAb into the central compartment
178 Administration of Anti-PD-1 mAb into the central compartment
179 Administration of Anti-PD-L1 mAb into the central compartment
180 Naïve T cells cycling into the lymph node
181 The proliferation rate of the Proliferating T cells in the lymph node
182 Appearance of monocytes in the tumor
183 Proliferation of cancer cells in the tumor
184 Distribution of Anti-CTLA-4 mAb between leaky tissues and lymph node
185 Distribution of Anti-CTLA-4 mAb between tight tissues and lymph node
186 Trafficking of free Effector T cells from Peripheral tissues vasculature to the lung vasculature
187 Turnover of free Effector T cells in the Peripheral tissues vasculature
188 Distribution of Anti-PD-1 mAb between leaky tissues and lymph node
189 Distribution of Anti-PD-1 mAb between tight tissues and lymph node
190 Distribution of Anti-PD-L1 mAb between leaky tissues and lymph node
191 Distribution of Anti-PD-L1 mAb between tight tissues and lymph node
192 CD80 expression by the T5 subtype of cancer cells in the tumor
193 PD-1 expression by the T2 subtype of cancer cells in the tumor
194 PD-1 expression by the T9 subtype of cancer cells in the tumor
195 CD80 expression by the T9 subtype of cancer cells in the tumor
196 PD-1 expression by the T6 subtype of cancer cells in the tumor
197 PD-L1 expression by the T6 subtype of cancer cells in the tumor
198 PD-1 expression by the T14 subtype of cancer cells in the tumor
199 PD-L1 expression by the T14 subtype of cancer cells in the tumor
200 CD80 expression by the T14 subtype of cancer cells in the tumor
201 PD-1 expression by the T10 subtype of cancer cells in the tumor
202 PD-L1 expression by the T10 subtype of cancer cells in the tumor
203 PD-L2 expression by the T10 subtype of cancer cells in the tumor
204 PD-1 expression by the T16 subtype of cancer cells in the tumor
205 PD-L1 expression by the T16 subtype of cancer cells in the tumor
206 PD-L2 expression by the T16 subtype of cancer cells in the tumor
207 CD80 expression by the T16 subtype of cancer cells in the tumor
208 PD-1 expression by the T7 subtype of cancer cells in the tumor
209 PD-L2 expression by the T7 subtype of cancer cells in the tumor
210 PD-1 expression by the T15 subtype of cancer cells in the tumor
211 PD-L2 expression by the T15 subtype of cancer cells in the tumor
212 CD80 expression by the T15 subtype of cancer cells in the tumor
213 PD-L1 expression by the T3 subtype of cancer cells in the tumor
214 PD-L1 expression by the T11 subtype of cancer cells in the tumor
215 CD80 expression by the T11 subtype of cancer cells in the tumor
216 PD-L1 expression by the T8 subtype of cancer cells in the tumor
217 PD-L2 expression by the T8 subtype of cancer cells in the tumor
218 PD-L1 expression by the T13 subtype of cancer cells in the tumor
219 PD-L2 expression by the T13 subtype of cancer cells in the tumor
220 CD80 expression by the T13 subtype of cancer cells in the tumor
221 PD-L2 expression by the T4 subtype of cancer cells in the tumor
222 PD-L2 expression by the T12 subtype of cancer cells in the tumor
223 CD80 expression by the T12 subtype of cancer cells in the tumor
224 Interaction at the immunological synapse between PD-1 expressed by the T10 subtype of cancer cells and Anti-PD-1 in the
tumor
225 PD-1 expression threshold by the T10 subtype of cancer cells in the tumor
226 Interaction at the immunological synapse between PD-L1 expressed by the T10 subtype of cancer cells and Anti-PD-L1 in the
tumor
227 PD-L1 expression threshold by the T10 subtype of cancer cells in the tumor
228 PD-L2 expression threshold by the T10 subtype of cancer cells in the tumor
229 Interaction at the immunological synapse between PD-L1 expressed by the T11 subtype of cancer cells and Anti-PD-L1 in the
tumor
230 PD-L1 expression threshold by the T11 subtype of cancer cells in the tumor
231 CD80 expression threshold by the T11 subtype of cancer cells in the tumor
232 PD-L2 expression threshold by the T12 subtype of cancer cells in the tumor
233 CD80 expression threshold by the T12 subtype of cancer cells in the tumor
234 Interaction at the immunological synapse between PD-L1 expressed by the T13 subtype of cancer cells and Anti-PD-L1 in the
tumor
235 PD-L1 expression threshold by the T13 subtype of cancer cells in the tumor
236 PD-L2 expression threshold by the T13 subtype of cancer cells in the tumor
237 CD80 expression by the T13 subtype of cancer cells in the tumor
238 Interaction at the immunological synapse between PD-1 expressed by the T14 subtype of cancer cells and PD-L1 on the
complementary Effector T cells in the tumor
239 PD-1 expression threshold by the T14 subtype of cancer cells in the tumor
240 Interaction at the immunological synapse between PD-L1 expressed by the T14 subtype of cancer cells and CD80 on the
complementary Effector T cells in the tumor
241 Interaction at the immunological synapse between PD-L1 expressed by the T14 subtype of cancer cells and Anti-PD-L1 in the
tumor
242 PD-L1 expression threshold by the T14 subtype of cancer cells in the tumor
243 Interaction at the immunological synapse between CD80 expressed by the T14 subtype of cancer cells and PD-L1 on the
complementary Effector T cells in the tumor
244 CD80 expression threshold by the T14 subtype of cancer cells in the tumor
245 Interaction at the immunological synapse between PD-1 expressed by the T15 subtype of cancer cells and Anti-PD-1 in the
tumor
246 PD-1 expression threshold by the T15 subtype of cancer cells in the tumor
247 Interaction at the immunological synapse between PD-L2 expressed by the T15 subtype of cancer cells and PD-1 on the
complementary Effector T cells in the tumor
248 PD-L2 expression threshold by the T15 subtype of cancer cells in the tumor
249 Interaction at the immunological synapse between CD80 expressed by the T15 subtype of cancer cells and PD-L1 on the
complementary Effector T cells in the tumor
250 CD80 expression threshold by the T15 subtype of cancer cells in the tumor
251 Interaction at the immunological synapse between PD-1 expressed by the T16 subtype of cancer cells and PD-L1 on the
complementary Effector T cells in the tumor
252 Interaction at the immunological synapse between PD-1 expressed by the T16 subtype of cancer cells and Anti-PD-1 in the
tumor
253 PD-1 expression threshold by the T16 subtype of cancer cells in the tumor
254 Interaction at the immunological synapse between PD-L1 expressed by the T16 subtype of cancer cells and Anti-PD-L1 in the
tumor
255 PD-L1 expression threshold by the T16 subtype of cancer cells in the tumor
256 Interaction at the immunological synapse between PD-L2 expressed by the T16 subtype of cancer cells and PD-1 on the
complementary Effector T cells in the tumor
257 PD-L2 expression threshold by the T16 subtype of cancer cells in the tumor
258 CD80 expression threshold by the T16 subtype of cancer cells in the tumor
259 PD-1 expression threshold by the T2 subtype of cancer cells in the tumor
260 PD-L1 expression threshold by the T3 subtype of cancer cells in the tumor
261 PD-L2 expression threshold by the T4 subtype of cancer cells in the tumor
262 CD80 expression threshold by the T5 subtype of cancer cells in the tumor
263 Interaction at the immunological synapse between PD-L2 expressed by the T6 subtype of cancer cells and PD-1 on the
complementary Effector T cells in the tumor
264 PD-1 expression threshold by the T6 subtype of cancer cells in the tumor
265 Interaction at the immunological synapse between PD-L1 expressed by the T6 subtype of cancer cells and PD-1 on the
complementary Effector T cells in the tumor
266 Interaction at the immunological synapse between PD-L1 expressed by the T6 subtype of cancer cells and CD80 on the
complementary Effector T cells in the tumor
267 Interaction at the immunological synapse between PD-L1 expressed by the T6 subtype of cancer cells and Anti-PD-L1 in the
tumor
268 PD-L1 expression threshold by the T6 subtype of cancer cells in the tumor
269 PD-1 expression threshold by the T7 subtype of cancer cells in the tumor
270 PD-L2 expression threshold by the T7 subtype of cancer cells in the tumor
271 Interaction at the immunological synapse between PD-L1 expressed by the T8 subtype of cancer cells and CD80 on Effector T
cells in the tumor
272 Interaction at the immunological synapse between PD-L1 expressed by the T8 subtype of cancer cells and Anti-PD-L1 in the
tumor
273 PD-L1 expression threshold by the T8 subtype of cancer cells in the tumor
274 PD-L2 expression threshold by the T8 subtype of cancer cells in the tumor
275 Interaction at the immunological synapse between PD-1 expressed by the T9 subtype of cancer cells and PD-L1 on the
complementary Effector T cells in the tumor
276 PD-1 expression threshold by the T9 subtype of cancer cells in the tumor
277 CD80 expression threshold by the T9 subtype of cancer cells in the tumor
278 Transendocytosis of the CD80 receptors on mAPCs through CTLA-4 binding and internalization on T Regulatory cells in the
tumor
279 Transendocytosis of the CD86 receptors on mAPCs through CTLA-4 binding and internalization on T Regulatory cells in the
tumor
280 Internalization of the Anti-CTLA-4 antibodies bound to CTLA-4 receptors on T Regulatory cells in the tumor
281 PD-1 expression by Effector T cells interacting with the T8 subtype of cancer cells in the tumor
282 CD80 expression by Effector T cells interacting with the T8 subtype of cancer cells in the tumor
283 PD-1 expression by Effector T cells interacting with the T3 subtype of cancer cells in the tumor
284 CD80 expression by Effector T cells interacting with the T3 subtype of cancer cells in the tumor
285 PD-L1 expression by Effector T cells interacting with the T16 subtype of cancer cells in the tumor
286 PD-1 expression by Effector T cells interacting with the T16 subtype of cancer cells in the tumor
287 CD80 expression by Effector T cells interacting with the T16 subtype of cancer cells in the tumor
288 PD-L1 expression by Effector T cells interacting with the T14 subtype of cancer cells in the tumor
289 PD-1 expression by Effector T cells interacting with the T14 subtype of cancer cells in the tumor
290 CD80 expression by Effector T cells interacting with the T14 subtype of cancer cells in the tumor
291 PD-L1 expression by Effector T cells interacting with the T10 subtype of cancer cells in the tumor
292 PD-1 expression by Effector T cells interacting with the T10 subtype of cancer cells in the tumor
293 CD80 expression by Effector T cells interacting with the T10 subtype of cancer cells in the tumor
294 PD-L1 expression by Effector T cells interacting with the T6 subtype of cancer cells in the tumor
295 PD-1 expression by Effector T cells interacting with the T6 subtype of cancer cells in the tumor
296 CD80 expression by Effector T cells interacting with the T6 subtype of cancer cells in the tumor
297 PD-L1 expression by Effector T cells interacting with the T15 subtype of cancer cells in the tumor
298 PD-1 expression by Effector T cells interacting with the T15 subtype of cancer cells in the tumor
299 PD-L1 expression by Effector T cells interacting with the T7 subtype of cancer cells in the tumor
300 PD-1 expression by Effector T cells interacting with the T7 subtype of cancer cells in the tumor
301 PD-L1 expression by Effector T cells interacting with the T13 subtype of cancer cells in the tumor
302 PD-1 expression by Effector T cells interacting with the T13 subtype of cancer cells in the tumor
303 PD-L1 expression by Effector T cells interacting with the T11 subtype of cancer cells in the tumor
304 PD-1 expression by Effector T cells interacting with the T11 subtype of cancer cells in the tumor
305 PD-L1 expression by Effector T cells interacting with the T12 subtype of cancer cells in the tumor
306 PD-1 expression by Effector T cells interacting with the T12 subtype of cancer cells in the tumor
307 PD-1 expression by Effector T cells interacting with the T4 subtype of cancer cells in the tumor
308 PD-L1 expression by Effector T cells interacting with the T9 subtype of cancer cells in the tumor
309 PD-L1 expression by Effector T cells interacting with the T5 subtype of cancer cells in the tumor
310 PD-L1 expression by Effector T cells interacting with the T2 subtype of cancer cells in the tumor
311 Interaction at the immunological synapse between PD-1 expressed by the T10 subtype of cancer cells and PD-L1 on the
complementary Effector T cells in the tumor
312 Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T10 subtype of
cancer cells and Anti-PD-L1 in the tumor
313 PD-L1 expression threshold by the Effector T cells interacting with the T10 subtype of cancer cells in the tumor
314 Interaction at the immunological synapse between PD-L1 expressed by the T10 subtype of cancer cells and PD-1 on the
complementary Effector T cells in the tumor
315 Interaction at the immunological synapse between PD-L2 expressed by the T10 subtype of cancer cells and PD-1 on the
complementary Effector T cells in the tumor
316 PD-1 expression threshold by the Effector T cells interacting with the T10 subtype of cancer cells in the tumor
317 Interaction at the immunological synapse between PD-L1 expressed by the T10 subtype of cancer cells and CD80 on the
complementary Effector T cells in the tumor
318 CD80 expression threshold by the Effector T cells interacting with the T10 subtype of cancer cells in the tumor
319 Interaction at the immunological synapse between PD-L1 expressed by the T11 subtype of cancer cells and CD80 on the
complementary Effector T cells in the tumor
320 Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T11 subtype of
cancer cells and Anti-PD-L1 in the tumor
321 PD-L1 expression threshold by the Effector T cells interacting with the T11 subtype of cancer cells in the tumor
322 Interaction at the immunological synapse between PD-L1 expressed by the T11 subtype of cancer cells and PD-1 on the
complementary Effector T cells in the tumor
323 PD-1 expression threshold by the Effector T cells interacting with the T11 subtype of cancer cells in the tumor
324 Interaction at the immunological synapse between CD80 expressed by the T12 subtype of cancer cells and PD-L1 on the
complementary Effector T cells in the tumor
325 Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T12 subtype of
cancer cells and Anti-PD-L1 in the tumor
326 PD-L1 expression threshold by the Effector T cells interacting with the T12 subtype of cancer cells in the tumor
327 Interaction at the immunological synapse between PD-L2 expressed by the T12 subtype of cancer cells and PD-1 on the
complementary Effector T cells in the tumor
328 PD-1 expression threshold by the Effector T cells interacting with the T12 subtype of cancer cells in the tumor
329 Interaction at the immunological synapse between CD80 expressed by the T13 subtype of cancer cells and PD-L1 on the
complementary Effector T cells in the tumor
330 PD-L1 expression threshold by the Effector T cells interacting with the T13 subtype of cancer cells in the tumor
331 Interaction at the immunological synapse between PD-L1 expressed by the T13 subtype of cancer cells and PD-1 on the
complementary Effector T cells in the tumor
332 Interaction at the immunological synapse between PD-L2 expressed by the T13 subtype of cancer cells and PD-1 on the
complementary Effector T cells in the tumor
333 Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T13 subtype of
cancer cells and Anti-PD-1 in the tumor
334 PD-1 expression threshold by the Effector T cells interacting with the T13 subtype of cancer cells in the tumor
335 Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T14 subtype of
cancer cells and Anti-PD-L1 in the tumor
336 PD-L1 expression threshold by the Effector T cells interacting with the T14 subtype of cancer cells in the tumor
337 Interaction at the immunological synapse between PD-L1 expressed by the T14 subtype of cancer cells and PD-1 on the
complementary Effector T cells in the tumor
338 PD-1 expression threshold by the Effector T cells interacting with the T14 subtype of cancer cells in the tumor
339 CD80 expression threshold by the Effector T cells interacting with the T14 subtype of cancer cells in the tumor
340 Interaction at the immunological synapse between PD-1 expressed by the T15 subtype of cancer cells and PD-L1 on the
complementary Effector T cells in the tumor
341 Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T15 subtype of
cancer cells and Anti-PD-L1 in the tumor
342 PD-L1 expression threshold by the Effector T cells interacting with the T15 subtype of cancer cells in the tumor
343 Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T15 subtype of
cancer cells and Anti-PD-1 in the tumor
344 PD-1 expression threshold by the Effector T cells interacting with the T15 subtype of cancer cells in the tumor
345 Interaction at the immunological synapse between CD80 expressed by the T16 subtype of cancer cells and PD-L1 on the
complementary Effector T cells in the tumor
346 Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T16 subtype of
cancer cells and Anti-PD-L1 in the tumor
347 PD-L1 expression threshold by the Effector T cells interacting with the T16 subtype of cancer cells in the tumor
348 Interaction at the immunological synapse between PD-L1 expressed by the T16 subtype of cancer cells and PD-1 on the
complementary Effector T cells in the tumor
349 Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T16 subtype of
cancer cells and Anti-PD-1 in the tumor
350 PD-1 expression threshold by the Effector T cells interacting with the T16 subtype of cancer cells in the tumor
351 Interaction at the immunological synapse between PD-L1 expressed by the T16 subtype of cancer cells and CD80 on the
complementary Effector T cells in the tumor
352 CD80 expression threshold by the Effector T cells interacting with the T16 subtype of cancer cells in the tumor
353 Interaction at the immunological synapse between PD-1 expressed by the T2 subtype of cancer cells and PD-L1 on the
complementary Effector T cells in the tumor
354 PD-L1 expression threshold by the Effector T cells interacting with the T2 subtype of cancer cells in the tumor
355 Interaction at the immunological synapse between PD-L1 expressed by the T3 subtype of cancer cells and PD-1 on the
complementary Effector T cells in the tumor
356 Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T3 subtype of
cancer cells and Anti-PD-1 in the tumor
357 PD-1 expression threshold by the Effector T cells interacting with the T3 subtype of cancer cells in the tumor
358 Interaction at the immunological synapse between PD-L1 expressed by the T3 subtype of cancer cells and CD80 on the
complementary Effector T cells in the tumor
359 CD80 expression threshold by the Effector T cells interacting with the T3 subtype of cancer cells in the tumor
360 Interaction at the immunological synapse between PD-L2 expressed by the T4 subtype of cancer cells and PD-1 on the
complementary Effector T cells in the tumor
361 Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T4 subtype of
cancer cells and Anti-PD-1 in the tumor
362 PD-1 expression threshold by the Effector T cells interacting with the T4 subtype of cancer cells in the tumor
363 Interaction at the immunological synapse between CD80 expressed by the T5 subtype of cancer cells and PD-L1 on the
complementary Effector T cells in the tumor
364 Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T5 subtype of
cancer cells and Anti-PD-L1 in the tumor
365 PD-L1 expression threshold by the Effector T cells interacting with the T5 subtype of cancer cells in the tumor
366 Interaction at the immunological synapse between PD-1 expressed by the T6 subtype of cancer cells and PD-L1 on the
complementary Effector T cells in the tumor
367 Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T6 subtype of
cancer cells and Anti-PD-L1 in the tumor
368 PD-L1 expression threshold by the Effector T cells interacting with the T6 subtype of cancer cells in the tumor
369 Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T6 subtype of
cancer cells and Anti-PD-1 in the tumor
370 PD-1 expression threshold by the Effector T cells interacting with the T6 subtype of cancer cells in the tumor
371 CD80 expression threshold by the Effector T cells interacting with the T6 subtype of cancer cells in the tumor
372 Interaction at the immunological synapse between PD-1 expressed by the T7 subtype of cancer cells and PD-L1 on the
complementary Effector T cells in the tumor
373 PD-L1 expression threshold by the Effector T cells interacting with the T7 subtype of cancer cells in the tumor
374 Interaction at the immunological synapse between PD-L2 expressed by the T7 subtype of cancer cells and PD-1 on the
complementary Effector T cells in the tumor
375 PD-1 expression threshold by the Effector T cells interacting with the T7 subtype of cancer cells in the tumor
376 Interaction at the immunological synapse between PD-L1 expressed by the T8 subtype of cancer cells and PD-1 on the
complementary Effector T cells in the tumor
377 Interaction at the immunological synapse between PD-L2 expressed by the T8 subtype of cancer cells and PD-1 on the
complementary Effector T cells in the tumor
378 PD-1 expression threshold by the Effector T cells interacting with the T8 subtype of cancer cells in the tumor
379 CD80 expression threshold by the Effector T cells interacting with the T8 subtype of cancer cells in the tumor
380 Interaction at the immunological synapse between CD80 expressed by the T9 subtype of cancer cells and PD-L1 on the
complementary Effector T cells in the tumor
381 Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T9 subtype of
cancer cells and Anti-PD-L1 in the tumor
382 PD-L1 expression threshold by the Effector T cells interacting with the T9 subtype of cancer cells in the tumor
383 Turnover of resting macrophages
384 Phagocytosis of tumor debris by resting APCs in the lymph node
385 Transport of tumor debris from the tumor to the lymph node
386 Decay of tumor debris in the tumor
387 The distribution of tumor debris away from any of the considered lymph nodes
388 Accounting for the distribution of tumor debris from the tumor to the lymph nodes other than the lymph node compartment in
the model
389 Natural turnover of cancer cells in the tumor
390 CD80 expression threshold by the mAPCs interacting with the T Regulatory cells in the tumor
391 Interaction at the immunological synapse between CD80 expressed by the Effector T cells and PD-L1 on the T Regulatory
cells in the tumor
392 CD80 expression threshold by the Effector T cells interacting with the T Regulatory cells in the tumor
393 CD80 expression threshold by the Effector T cells interacting with the MDSCs in the tumor
394 CD86 expression threshold by the mAPCs interacting with the T Regulatory cells in the tumor
395 Flow of Anti-CTLA-4 mAb between the tumor and lymph node
396 Interaction at the immunological synapse between CD80 expressed by the mAPCs and CTLA-4 on the T Regulatory cells in
the tumor
397 Interaction at the immunological synapse between CD86 expressed by the mAPCs and CTLA-4 on the T Regulatory cells in
the tumor
398 Interaction at the immunological synapse between CTLA-4 expressed by the T Regulatory cells and Anti-CTLA-4 in the
tumor
399 CTLA-4 expression threshold by the T Regulatory cells interacting with the mAPCs in the tumor
400 Turnover of Effector T cells in the tumor
401 Apoptosis of Effector T cells following complete cancer cell death in the tumor
402 Conversion of Effector T cells into Resident Effector Memory cells following complete cancer cell death in the tumor
403 Association of Effector T cells with cancer cells in the tumor
404 Turnover of arrested Effector T cells in Tumor vasculature
405 Extravasation of arrested Effector T cells into Tumor interstitium
406 Turnover of bound Effector T cells in Tumor vasculature
407 Arrest of bound Effector T cells in the Tumor vasculature
408 Detachment of bound Effector T cells in the Tumor vasculature
409 Binding or free Effector T cells to the Tumor vasculature
410 Trafficking of free Effector T cells from the Tumor vasculature to the Lungs vasculature
411 Turnover of free Effector T cells in Tumor vasculature
412 Transport of mAPCs from the tumor to the lymph node
413 Accounting for the distribution of mAPCs from the tumor to the lymph nodes other than the lymph node compartment in the
model
414 The distribution of mAPCs away from any of the considered lymph nodes
415 CD80 expression by mAPCs interacting with the T Regulatory cells in the tumor
416 CD86 expression by mAPCs interacting with the T Regulatory cells in the tumor
417 Association of Effector T cells with MDSCs in the tumor
418 PD-1 expression by MDSCs interacting with the Effector T cells in the tumor
419 PD-L1 expression by MDSCs interacting with the Effector T cells in the tumor
420 Dissociation of MDSCs from Effector T cells with inactivation of the latter in the tumor
421 Dissociation of MDSCs from Effector T cells without inactivation of the latter in the tumor
422 Distribution of Anti-PD-1 mAb between Tumor and Lymph Node
423 Interaction at the immunological synapse between PD-1 expressed by the T14 subtype of cancer cells and Anti-PD-1 in the
tumor
424 Interaction at the immunological synapse between PD-1 expressed by the T2 subtype of cancer cells and Anti-PD-1 in the
tumor
425 Interaction at the immunological synapse between PD-1 expressed by the T7 subtype of cancer cells and Anti-PD-1 in the
tumor
426 Interaction at the immunological synapse between PD-1 expressed by the T9 subtype of cancer cells and Anti-PD-1 in the
tumor
427 Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T10 subtype of
cancer cells and Anti-PD-1 in the tumor
428 Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T11 subtype of
cancer cells and Anti-PD-1 in the tumor
429 Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T12 subtype of
cancer cells and Anti-PD-1 in the tumor
430 Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T14 subtype of
cancer cells and Anti-PD-1 in the tumor
431 Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T7 subtype of
cancer cells and Anti-PD-1 in the tumor
432 Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T8 subtype of
cancer cells and Anti-PD-1 in the tumor
433 Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the T Regulatory
cells and Anti-PD-1 in the tumor
434 Interaction at the immunological synapse between PD-1 expressed by the MDSCs interacting with Effector T cells and Anti-
PD-1 in the tumor
435 Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells and PD-1 on the MDSCs in the
tumor
436 PD-1 expression threshold by the MDSCs interacting with the Effector T cells in the tumor
437 Interaction at the immunological synapse between PD-1 expressed by the Effector T cells and PD-L1 on the T Regulatory cells
in the tumor
438 PD-1 expression threshold by the Effector T cells interacting with the T Regulatory cells in the tumor
439 Interaction at the immunological synapse between PD-1 expressed by the Effector T cells interacting with the MDSCs and
Anti-PD-1 in the tumor
440 PD-1 expression threshold by the Effector T cells interacting with the MDSCs in the tumor
441 Interaction at the immunological synapse between PD-1 expressed by the T Regulatory cells interacting with the Effector T
cells and Anti-PD-1 in the tumor
442 PD-1 expression threshold by the T Regulatory cells interacting with the Effector T cells in the tumor
443 Distribution of Anti-PD-L1 mAb between Tumor and Lymph Node
444 Interaction at the immunological synapse between PD-L1 expressed by the T3 subtype of cancer cells and Anti-PD-L1 in the
tumor
445 Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T13 subtype of
cancer cells and Anti-PD-L1 in the tumor
446 Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T2 subtype of
cancer cells and Anti-PD-L1 in the tumor
447 Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T7 subtype of
cancer cells and Anti-PD-L1 in the tumor
448 Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the T Regulatory
cells and Anti-PD-L1 in the tumor
417 Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells interacting with the MDSCs and
Anti-PD-L1 in the tumor
418 Interaction at the immunological synapse between CD80 expressed by the Effector T cells and PD-L1 on the MDSCs in the
tumor
419 Interaction at the immunological synapse between PD-1 expressed by the Effector T cells and PD-L1 on the MDSCs in the
tumor
420 Interaction at the immunological synapse between PD-L1 expressed by the MDSCs interacting with the Effector T cells and
Anti-PD-L1 in the tumor
421 PD-L1 expression threshold by the MDSCs interacting with the Effector T cells in the tumor
422 Interaction at the immunological synapse between PD-L1 expressed by the Effector T cells and PD-1 on the T Regulatory cells
in the tumor
423 PD-L1 expression threshold by the Effector T cells interacting with the T Regulatory cells in the tumor
424 PD-1 expression threshold by the Effector T cells interacting with the MDSCs in the tumor
425 Interaction at the immunological synapse between PD-L1 expressed by the T Regulatory cells interacting with the Effector T
cells and Anti-PD-L1 in the tumor
426 PD-1 expression threshold by the T Regulatory cells interacting with the Effector T cells in the tumor
427 Recovery of Effector T cells from the delay state following interaction with cancer cells in the tumor
428 Generation of cancer debris by killing of the cancer cells by the Effector T cells in the tumor
429 Dissociation of Effector T cells from the cancer cells into a delay state in the tumor
430 Inactivation of Effector T cells as a result of interactions with the cancer cells in the tumor
431 CD80 expression by Effector T cells interacting with the MDSCs in the tumor
432 PD-1 expression by Effector T cells interacting with the MDSCs in the tumor
433 PD-L1 expression by Effector T cells interacting with the MDSCs in the tumor
434 CD80 expression by Effector T cells interacting with the T Regulatory cells in the tumor
435 PD-1 expression by Effector T cells interacting with the T Regulatory cells in the tumor
436 PD-L1 expression by Effector T cells interacting with the T Regulatory cells in the tumor
437 Association of Effector T cells with T Regulatory cells in the tumor
438 CTLA-4 expression by T Regulatory cells interacting with the mAPCs in the tumor
439 PD-1 expression by T Regulatory cells interacting with the Effector T cells in the tumor
440 PD-L1 expression by T Regulatory cells interacting with the Effector T cells in the tumor
441 Dissociation of T Regulatory cells from Effector T cells with inactivation of the latter in the tumor
442 Dissociation of T Regulatory cells from Effector T cells without inactivation of the latter in the tumor